NCKU News Center

Welcome to NCKU
:::
:::

First Taiwanese Recipient of SEBM Distinguished Scientist Award

Tainan, Taiwan, April 19th, 2011

Dr. Nan-Shan Chang, Professor and Chair of the Institute of Molecular Medicine at National Cheng Kung University (NCKU), Tainan, Taiwan, is one of the 9 recipients of the 2011 Distinguished Scientist Award by the US-based Society for Experimental Biology and Medicine (SEBM).

The awards were presented at the Society’s annual Experimental Biology Meeting (EB2011) held at the Grand Hyatt Washington Hotel on April 10th.

According to the congratulatory letter Dr. Chang received from the SEBM President Susan E. Mulroney, the SEBM Distinguished Scientist Award was established in 2010 to honor SEBM members who have made seminal contributions to biomedical research and the advancement of SEBM. Dr. Chang is the first member from Taiwan receiving the award.

The Society for Experimental Biology and Medicine (SEBM), founded in 1903, is an organization aiming to promote biomedical research and facilitate scientific exchange among disciplines. It currently has 508 members, including 15 members from Taiwan.

Dr. Chang joined NCKU on November 13, 2006. Since then, he has received 3 highly recognized awards, including Breast Cancer Concept Award from the Department of Defense (DoD) USA in 2008, Neurofibromatosis Research Award from DoD USA in 2010, and the SEBM Award this year. In addition, under his direction, Ms. Jean-Yun Chang, a second-year student in the Master-degree program, received the highly competitive Travel Award from the prestigious American Society for Biochemistry and Molecular Biology (ASBMB) to attend the EB2008 conference in New Orleans in 2008.

Dr. Chang was trained in immunology and received his Ph.D. degree from the Medical University of South Carolina in 1984. He joined the University of Massachusetts Medical Center as a junior faculty in 1987, and became a full-time faculty at the Guthrie Research Institute in Pennsylvania in 1989. Dr. Chang is most noted for his discovery of a tumor suppressor WW domain-containing oxidoreductase (WWOX) in year 2000. Dr. Chang has been leading in the field, and invited for lectures and seminars in universities and symposia around the globe for 47 times since then. The WWOX gene plays a crucial role in controlling cancer progression. Alteration of this gene may lead to cancer initiation and non-stop growth.

The announcement was released on April 1, the same date the Ministry of Education, Taiwan, announced a grant of NT$1.6 billion (US$55 million) for NCKU. Chang’s winning the award is one reference to the excellent research performance of NCKU.
Click Num  
Forward to friend
Please input CAPTCHA